Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report

INTRODUCTION: Rituximab is an emerging treatment for autoimmune hemolytic anemia. We report the case of a patient with a five-year complete hematologic response to a third course of treatment with rituximab. Cases of response to rituximab re-treatments have been reported, but none to our knowledge t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abadie, Kathleen, Hege, Kristen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077666/
https://www.ncbi.nlm.nih.gov/pubmed/24889270
http://dx.doi.org/10.1186/1752-1947-8-175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077666/
https://www.ncbi.nlm.nih.gov/pubmed/24889270
http://dx.doi.org/10.1186/1752-1947-8-175

Ejemplares similares